Inside information: Nightingale Health and Innoquest Diagnostics enter into collaboration agreement to make Nightingale Health’s technology accessible in the Southeast Asia region
Company release, Inside information15 November 2023, at 9:15 a.m. (EET)
Nightingale Health, the health risk detection and preventative health pioneer, and Innoquest Diagnostics (“Innoquest”), a leading clinical diagnostics service provider in Singapore, have joined forces to enable access to Nightingale Health’s blood analysis technology in Southeast Asia.
Innoquest is a subsidiary of Pathology Asia, one of the largest diagnostic service providers in Southeast Asia. Pathology Asia currently operates laboratories in Singapore, Malaysia, Vietnam, Philippines, Thailand, Indonesia, and